Insa Winzenborg
8PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 08, 2025
IQ Survey Results on Current Industry Practices: Part 2-Quantitative Evaluations of Immunogenicity Assessment.Susan Richards, Insa Winzenborg, Doreen Luedtke
|Jun 12, 2024
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis.Neha Thakre, Aline Goebel, Insa Winzenborg
|Jan 24, 2024
Risankizumab: Mechanism of action, clinical and translational science.Yinuo Pang, Ronilda D'Cunha, Insa Winzenborg
|Jun 13, 2022
Interdisciplinary model-informed drug development for extending duration of elagolix treatment in patients with uterine fibroids.Denise Beck, Insa Winzenborg, Wei Gao
|Dec 08, 2021
Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids.Denise Beck, Insa Winzenborg, Mohan Liu
|Jul 05, 2020
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model.Insa Winzenborg, Akshanth R Polepally, Ahmed Nader
Pageof 2
Frequent Collaborators
3 joint publications
Ahmed Nader
3 joint publications
Akshanth R Polepally
3 joint publications
Mohamad Shebley
2 joint publications
Juki W Ng
2 joint publications
Nael M Mostafa
2 joint publications
Peter Noertersheuser
2 joint publications
Yinuo Pang
2 joint publications
Ronilda D'Cunha
1 joint publications
Cheri E Klein
1 joint publications
Denise Beck
